Laddar...
Chimeric antigen receptor–engineered T cells as oncolytic virus carriers
The use of engineered T cells in adoptive transfer therapies has shown significant promise in treating hematological cancers. However, successes treating solid tumors are much less prevalent. Oncolytic viruses (OVs) have the capacity to induce specific lysis of tumor cells and indirectly impact tumo...
Sparad:
| I publikationen: | Mol Ther Oncolytics |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4782951/ https://ncbi.nlm.nih.gov/pubmed/27119109 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mto.2015.14 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|